Visceral adipose tissue: the link with esophageal adenocarcinoma

References

• Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008;100:1184–7.
   PubMed Web of Science ®Google Scholar
• Dikken JL, Lemmens VE, Wouters MW, et al. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer 2012;48:1624–32.
   PubMed Web of Science ®Google Scholar
• Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143:199–211.
   PubMed Web of Science ®Google Scholar
• Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:872–8.
   PubMed Web of Science ®Google Scholar
• Ryan AM, Duong M, Healy L, et al. Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets. Cancer Epidemiol 2011;35:309–19.
   PubMed Web of Science ®Google Scholar
• Corley DA, Kubo A, Zhao W. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev 2008;17:352–8.
   PubMed Web of Science ®Google Scholar
• Steffen A, Schulze MB, Pischon T, et al. Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2009;18:2079–89.
   PubMed Web of Science ®Google Scholar
• Seidell JC, Oosterlee A, Deurenberg P, Hautvast JG, Ruijs JH. Abdominal fat depots measured with computed tomography: effects of degree of obesity, sex, and age. Eur J Clin Nutr 1988;42:805–15.
   PubMed Web of Science ®Google Scholar
• van der Kooy K, Leenen R, Seidell JC, Deurenberg P, Droop A, Bakker CJ. Waist-hip ratio is a poor predictor of changes in visceral fat. Am J Clin Nutr 1993;57:327–33.
   PubMed Web of Science ®Google Scholar
• Abnet CC, Freedman ND, Hollenbeck AR, Fraumeni JF Jr, Leitzmann M, Schatzkin A. A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. Eur J Cancer 2008;44:465–71.
   PubMed Web of Science ®Google Scholar
• Merry AH, Schouten LJ, Goldbohm RA, van den Brandt PA. Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study. Gut 2007;56:1503–11.
   PubMed Web of Science ®Google Scholar
• Akiyama T, Yoneda M, Inamori M, et al. Visceral obesity and the risk of Barrett's esophagus in Japanese patients with non-alcoholic fatty liver disease. BMC Gastroenterol 2009;9:56.
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Kvapil P, Hacken-Bitar J, Kramer JR. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol 2005;100:2151–6.
   PubMed Web of Science ®Google Scholar
• Nelsen EM, Kirihara Y, Takahashi N, et al. Distribution of body fat and its influence on esophageal inflammation and dysplasia in patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2012;10:728–34; quiz e61–2.
   PubMed Web of Science ®Google Scholar
• Beddy P, Howard J, McMahon C, et al. Association of visceral adiposity with oesophageal and junctional adenocarcinomas. Br J Surg 2010;97:1028–34.
   PubMed Web of Science ®Google Scholar
• Bozzetti F, Group SW. Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer 2009;17:279–84.
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Correa AM, Hofstetter WL, et al. Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis. Dis Esophagus 2012;25:614–22.
   PubMed Web of Science ®Google Scholar
• Stoop EM, de Haan MC, de Wijkerslooth TR, et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol 2012;13:55–64.
   PubMed Web of Science ®Google Scholar
• Goodpaster BH. Measuring body fat distribution and content in humans. Curr Opin Clin Nutr Metab Care 2002;5:481–7.
   PubMed Web of Science ®Google Scholar
• Kvist H, Chowdhury B, Grangard U, Tylen U, Sjostrom L. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr 1988;48:1351–61.
   PubMed Web of Science ®Google Scholar
• van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 2012;99:550–7.
   PubMed Web of Science ®Google Scholar
• Shiely F, Perry IJ, Lutomski J, et al. Temporal trends in misclassification patterns of measured and self-report based body mass index categories–findings from three population surveys in Ireland. BMC Public Health 2010;10:560.
   PubMed Web of Science ®Google Scholar
• Tisdale MJ. Cancer cachexia. Curr Opin Gastroenterol 2010;26:146–51.
   PubMed Web of Science ®Google Scholar
• Pontiroli AE, Pizzocri P, Librenti MC, et al. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 2002;87:3555–61.
   PubMed Web of Science ®Google Scholar
• Agustsson T, Wikrantz P, Ryden M, Brismar T, Isaksson B. Adipose tissue volume is decreased in recently diagnosed cancer patients with cachexia. Nutrition 2012;28:851–5.
   PubMed Web of Science ®Google Scholar
• Statistic Netherlands. 2012. Accessed at http://www.cbs.nl.
   Google Scholar
• den Hoed CM, van Blankenstein M, Dees J, Kuipers EJ. The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma. Br J Cancer 2011;105:200–5.
   PubMed Web of Science ®Google Scholar
• El-Serag H. Role of obesity in GORD-related disorders. Gut 2008;57:281–4.
   PubMed Web of Science ®Google Scholar
• Kahrilas PJ, Boeckxstaens G. Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients? Gut 2012;61:1501–9.
   PubMed Web of Science ®Google Scholar
• Wu JC, Mui LM, Cheung CM, Chan Y, Sung JJ. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology 2007;132:883–9.
   PubMed Web of Science ®Google Scholar
• Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548–56.
   PubMed Web of Science ®Google Scholar
• Donohoe CL, Doyle SL, Reynolds JV. Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr 2011;3:12.
   PubMed Web of Science ®Google Scholar
• Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–78.
   PubMed Web of Science ®Google Scholar
• Ogunwobi OO, Beales IL. Leptin stimulates the proliferation of human esophageal adenocarcinoma cells via HB-EGF and Tgfalpha mediated transactivation of the epidermal growth factor receptor. Br J Biomed Sci 2008;65:121–7.
   PubMed Web of Science ®Google Scholar
• Ogunwobi OO, Beales IL. Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated esophageal adenocarcinoma cell proliferation. Mol Cell Endocrinol 2008;285:43–50.
   PubMed Web of Science ®Google Scholar
• van Kruijsdijk RC, van der Wall E, Visseren FL. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 2009;18:2569–78.
   PubMed Web of Science ®Google Scholar